|Podcasts|September 1, 2022 (Updated: September 29, 2022)
The Quest To Counter Alzheimer’s
Author(s)Elaine Quilici, Miranda Schmalfuhs
In episode 116, Dr. Greg Rippon, vice president and chief medical partner at Genentech, discusses his work in Alzheimer’s and his outlook for the future of the therapeutic space.
Advertisement
In episode 116, Dr. Greg Rippon, vice president and chief medical partner at Genentech, discusses his work in Alzheimer’s and his outlook for the future of the therapeutic space.
This podcast sponosored by
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
uniQure and FDA Clash Over Regulatory Decision for Huntington’s Disease Therapy: Report
2
AI's Inflection Point: Bridging the Adoption and ROI Gap
3
Advancing Full-Spectrum Cannabis Through FDA
4
Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options
5